The McElrath laboratory is dedicated to understanding the human immune response mechanisms in HIV infection and resistance in a way that can be translated into the development of an efficacious HIV vaccine.  The laboratory applies multi-disciplinary and cross-platform approaches to their studies, which encompass the following research areas:

• HIV Vaccine Trials Network (HVTN) Laboratory

• Seattle HIV Vaccine Trials Unit (HVTU)

• Collaboration for AIDS Vaccine Discovery (CAVD)

• Immune Correlates

• Long Term Non-Progressor Cohort (LTNP)

• Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC)

• Microbicide Trials Network

 

For additional information about the McElrath Laboratory, see the links below:

• McElrath publications
• Contact us
• About M. Juliana McElrath